DNA Script company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Series C - II | Alive

Total Raised


Last Raised

$35M | 6 mos ago

About DNA Script

DNA Script is a biotech start-up that manufactures de novo synthetic nucleic acids using an enzymatic technology. The company aims to introduce a biochemical process for DNA and RNA synthesis based on the use of efficient enzymes. This technology mimics the way nature produces genetic code and enables enhanced performance while minimizing the use of harsh chemicals.

DNA Script Headquarter Location

67 avenue de Fontainebleau

Le Kremlin-Bicetre, 94270,


+33 1 56 20 56 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing DNA Script

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned DNA Script in 1 CB Insights research brief, most recently on Oct 5, 2021.

Expert Collections containing DNA Script

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

DNA Script is included in 3 Expert Collections, including Synthetic Biology.


Synthetic Biology

238 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

DNA Script Patents

DNA Script has filed 18 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Biotechnology, Genetics, DNA, DNA replication


Application Date


Grant Date



Related Topics

Molecular biology, Biotechnology, Genetics, DNA, DNA replication



Latest DNA Script News

Worldwide DNA Synthesis Technologies and Services Industry to 2035 - Players Include Ajinomoto Bio-Pharma Services, ATUM and DNA Script - ResearchAndMarkets.com

Jun 20, 2022

This report features report features a detailed study of the current scenario and future potential of the DNA synthesis technologies and service providers. Further, the study underlines an in-depth analysis, highlighting the capabilities of service providers engaged in this domain. DNA or RNA molecules find a variety of applications in the biopharmaceutical industry for genetic testing, medical research, therapeutic development, forensic investigation, and other analytical processes. It is worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions. The approval of the first antisense oligonucleotide drug, Fomivirse, in 1998, led to a surge in the demand of DNA-based interventions. In addition to the application of DNA in therapy development, these entities are also being deployed in genetic diagnostics and have already proven their use in identifying patients across a diverse range of diseases including breast cancer, dyslexia, ovarian cancer, Parkinson's disease and psoriasis. The advances in medical research have led to establishment of several technologies that can sequence, analyze, and edit different forms of DNA. This, coupled to the increasing use of DNA across diverse range of applications, have urged industry experts to actively look for efficient DNA synthesis technologies that not only facilitate parallelized synthesis of DNA but also provide unmatched precision, scalability, and speed. It is worth noting that several companies have developed proprietary enzymatic DNA synthesis platforms offering distinct advantages (such as the potential to increase length of DNA fragment, greater accessibility and convenience) over conventional DNA synthesis methods. Given the known merits of such technologies, a significant proportion of medical researchers and therapy / diagnostic developers prefer to outsource DNA synthesis operations to third party platforms / service providers who claim to provide the expertise in DNA synthesis and production. Presently, there are over 65 players that offer DNA synthesis technologies / services, and these players are actively undertaking efforts to build / expand their existing capabilities, in order to cater to the growing demand for DNA synthesis. Given the rising need for DNA across a wide range of applications, we are led to believe that the DNA synthesis platforms and services industry is likely to witness noteworthy growth in the foreseen future. Companies Mentioned Eurofins Genomics Who are the leading industry players offering DNA synthesis technologies and services? What are the recent developments and emerging trends in the DNA synthesis technologies and services domain? Which partnership models are commonly adopted by industry stakeholders in the DNA synthesis technologies and services industry? Which are the leading funding organizations providing grants in the DNA synthesis industry? What is the trend of capital investments in the DNA synthesis technologies and services market? What is the focus of various publications related to DNA synthesis technologies and services? How has the intellectual property landscape for DNA synthesis technologies and services market evolved over the years? Which factors are likely to influence the evolution of the upcoming DNA synthesis technologies and services market? How is the current and future opportunity likely to be distributed across key market segments? Key Topics Covered:

DNA Script Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

DNA Script Rank

  • When was DNA Script founded?

    DNA Script was founded in 2014.

  • Where is DNA Script's headquarters?

    DNA Script's headquarters is located at 67 avenue de Fontainebleau, Le Kremlin-Bicetre.

  • What is DNA Script's latest funding round?

    DNA Script's latest funding round is Series C - II.

  • How much did DNA Script raise?

    DNA Script raised a total of $335.04M.

  • Who are the investors of DNA Script?

    Investors of DNA Script include T. Rowe Price, eureKARE, Irving Investors, Sino Biopharmaceutical, Baillie Gifford & Co. and 26 more.

  • Who are DNA Script's competitors?

    Competitors of DNA Script include Catalog Technologies.

You May Also Like

Kilobaser Logo

KioBaser is building what it dubs "Nespresso machine of DNA synthesis". The machine creates DNA primers, a short single strand of RNA or DNA (generally about 18-22 bases) that serves as a starting point for DNA synthesis.

Evonetix Logo

Evonetix develops a desktop, short-latency solution to synthesize DNA to facilitate the field of synthetic biology, with application across industries including healthcare, pharma, biotech, food and agriculture and data storage.

Molecular Assemblies Logo
Molecular Assemblies

Molecular Assemblies develops an enzymatic DNA synthesis technology designed to power DNA-based products. Enzymatic DNA synthesis can write long, pure DNA, which is required to free the potential of synthetic biology applications, such as personalized medicines (including CAR-T cell therapies and CRISPR gene editing) and advanced agricultural and industrial products, through gene development and DNA-based data storage.

Helixworks Technologies

Helixworks Technologies is a biotechnology company specializing in DNA synthesis.


Iridia is developing a DNA-based data storage solution. By combining DNA polymer synthesis technology, electronic nano-switches and semiconductor fabrication technologies, Iridia is developing a highly-parallel format to enable an array of nanomodules with the potential to store data at exceptionally high density.


Developer of instrumentation for gene synthesis analysis. The company develops a DNA and RNA synthesizer for molecular biology research purposes. The platform aims to deliver less expensive, higher quality, reduced turn-around-time oligonucleotide synthesis solutions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.